Beckman Coulter Diagnostics

Trusted

https://www.beckmancoulter.com/

Last activity: 23.02.2026

Active

Categories: AutomationCommerceDiagnosticsHealthTechIndustryLabMedtechScienceTechnologyTime

Beckman Coulter Diagnostics advances healthcare for every person

Facebook LinkedIn Email

Followers

1.48K

Followers

260.63K

Website visits

104.9K /mo.

Mentions

Overview

Location

United States, California, Brea

Employees

10001+

Founded date

1935

Mentions in press and media 31

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Feb 17, 2026	Katalysen Ventures publishes report for the Fourth Quarter 2025	Katalysen Ventures publishes report for the Fourth Quarter 2025 Tue, Feb 17, 2026 08:13 CET Report this content Katalysen Ventures AB (publ) hereby publishes the report for the Fourth Quarter 2025. The full report is available immediately a...
Feb 15, 2026	The University Of Tulsa’s Hurricane Ventures Invests In AI Bioprocess Platform BioReact	The University of Tulsa and its venture fund, Hurricane Ventures, announced an investment in BioReact, an artificial intelligence and analytics platform designed to power modern bioprocess development and optimization. The funding will be u...
Jan 30, 2026	Automata: $45 Million Series C Closed To Build Operating System For AI Ready Labs	Automata, a London-based lab automation company focused on fully integrated platforms for life sciences, announced it has closed a $45 million Series C funding round led by Dimension. The company said the financing included participation fr...
Nov 6, 2025	OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study	BELLEVUE, Wash., Nov. 6, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospita...
Oct 17, 2025	S4DX Launches First UK Pilot, Strengthening Position in Rapidly Evolving Blood Diagnostics Market	S4DX Launches First UK Pilot, Strengthening Position in Rapidly Evolving Blood Diagnostics Market Fri, Oct 17, 2025 14:46 CET Report this content Katalysen Ventures AB (publ) (“Katalysen”) is pleased to announce that its portfolio venture a...
Oct 16, 2025	Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics	Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics Thu, Oct 16, 2025 10:26 CET Report this content The diagnostics company Gradientech today announces a new scientific publication confirming the QuickMIC® system to ...
Jul 24, 2025	EmeritusDX Launches Advanced Hematopathology Services, Expanding Rapidly Growing Test Portfolio	Headquarters Synatra™ personalized resulting system and ClearLLab™ Flow Cytometry platform to deliver precise, patient-specific insights that elevate care for hematologic malignancies. LAKE FOREST, Calif., July 24, 2025 /PRNewswire-PRWeb/ -...
Aug 14, 2024	NeuroTherapia Secures $12.3 Million to Combat Neuroinflammation in Alzheimer’s Disease	In the ever-evolving landscape of biotechnology, NeuroTherapia stands out as a beacon of hope. This clinical-stage company, nestled within the Cleveland Clinic Innovations portfolio, has recently secured $12.3 million in Series B funding. T...
Aug 9, 2024	Biotechnology Research Roles at Danaher Corporation	Share Tweet Share Share Email Biotechnology is a fast growing field that merges the boundaries of biology and technology to create innovative solutions for some of the world’s most pressing challenges. From developing new pharmaceuticals to...
Apr 1, 2024	Beckman Foundation Hosts Irvine Tech Week Forum Exploring Future of Life Sciences Tech	Beckman Foundation’s Life Sciences Tech & Trends Forum will provide attendees with important information about the state of the industry as well as insight about what its future holds. Orange County Institution Invites Panel of Industry...
Mar 11, 2024	Clinical Architecture Hosting Healthcare Thought Leadership Sessions at HIMSS 2024	Visit our in-booth (#2281) Data Quality Theater in Orlando This year, we're especially excited to introduce our Data Quality Theater. It will feature panels with industry thought leaders and influencers, who will share their insights on dat...
Sep 13, 2022	Beckman Coulter acquires Dublin biotech company ValitaCell	Dublin biotech company ValitaCell has been acquired by Beckman Coulter Life Sciences, based in Indianapolis. ValitaCell creates analytical technologies and products for the biopharmaceutical industry, with the aim of reducing the cost and t...
May 19, 2021	Beckman Coulter Launches Fully Quantitative and Automated COVID-19 IgG Test to Assess Antibody Immune Response Levels
May 4, 2021	Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
Apr 28, 2021	FAQ: What type of assay is the Gentian Calprotectin Immunoassay GCAL®?	What type of assay is GCAL®? In our Frequently Asked Questions about calprotectin series we will answer questions we often receive about plasma and serum calprotectin and the Gentian Calprotectin Immunoassay GCAL®. If you have any additiona...
Mar 23, 2021	Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
Jan 7, 2021	Gentian Diagnostics : Cystatin C - recommended by KDIGO and NICE	Cystatin C is superior biomarker of renal function1 and it is recommended by KDIGO2 and NICE3. Glomerular filtration rate (GFR) calculations that are performed by using cystatin C are independent of protein intake, ethnicity and muscle mass...
Dec 18, 2020	Beckman Coulter seeks authorization for $4 antigen test	Called the Access SARS-Cov-2 Antigen assay, the test is designed to detect proteins found on the surface of the SARS-Cov-2 virus, which can indicate an ongoing infection. It still must be administered by a healthcare provider, as it uses a ...
Dec 18, 2020	Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
Oct 15, 2020	Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
Oct 9, 2020	Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
Aug 24, 2020	Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs
Jul 21, 2020	Israeli Hospital Launches Innovative “Mega Lab” to Improve Lab Results & Patient Care	What You Should Know: – Israel’s Sheba Medical Center launches “Mega Lab” solution that improves patient care through lab technology advances that expedite lab test results and decrease human error. – The “Mega Lab” simultaneously processes...
Jul 19, 2020	Can You Get Covid-19 Coronavirus Twice? Here Is An Update On Immunity	Sweden's controversial "herd immunity" strategy depends heavily on the hope that infection with the ... [+] Covid-19 coronavirus will confer long lasting immunity. Here people stand in line and interact without social distancing o...
Dec 14, 2012	Beckman Coulter Use InterSystems Ensemble Integration Platform to Streamline Automated Pathology Services	New Solution Eliminates Manual Booking of Laboratory Samples ETON, UK – 14 December 2012 – InterSystems, a global leader in software for connected care, today announced that Beckman Coulter, one of the world’s leading manufacturers of clini...
Nov 30, 2010	Clinical Data sheds last assets of genetics and testing business	Clinical Data Inc. (NSDQ:CLDA) offloaded its its Familion testing and pharmacogenomics biomarker assetts to molecular diagnostics developer Transgenomic Inc. (OTC:TBIO) for $15.4 million, primarily in cash and notes. The assets represent th...
Jul 26, 2010	Beckman Coulter chops outlook after disappointing Q2	Beckman Coulter Inc. (NYSE:BEC) reduced its full-year guidance, again. The Orange County, Calif.-based biomedical testing systems maker reported net earnings of $60 million, or 84 cents per diluted share, on revenue of $902 million during t...
Apr 30, 2010	Recall could cost Beckman Coulter $50 million this year	Despite hefty top-line contributions expected from a recent acquisition, Beckman Coulter Inc. (NYSE:BEC) is scaling back its fiscal guidance for the rest of the year while it works to resolve a recall of its test for heart attacks and other...
Nov 12, 2007	Abcam announces laboratory collaboration	Abcam announces laboratory collaboration 12-11-2007 Abcam plc and Beckman Coulter, Inc. have announced a major bioscience collaboration - to create one of the world's most sophisticated, automated systems for the production of monoclonal an...
	Beckman Coulter seeks authorization for $4 antigen test	As the Department of Health and Human Services purchases more of Abbott’s rapid antigen tests, competitor Beckman Coulter said it is seeking an emergency use authorization for its $4 antigen test. The Brea, Calif.-based device and diagnosti...

Reviews 0

FAQ about Beckman Coulter Diagnostics

When was Beckman Coulter Diagnostics founded?

Beckman Coulter Diagnostics was founded in 1935.

What has the press written about Beckman Coulter Diagnostics?

Parsers VC has collected 31 articles mentioning Beckman Coulter Diagnostics, among them “Katalysen Ventures publishes report for the Fourth Quarter 2025” (Feb 17, 2026) and “The University Of Tulsa’s Hurricane Ventures Invests In AI Bioprocess Platform BioReact” (Feb 15, 2026).

Is Beckman Coulter Diagnostics still active?

Yes, Beckman Coulter Diagnostics is active; its latest activity on Parsers VC dates from Feb 23, 2026.